Inventor · disambiguated record
Werner Mueller
Also filed as: MUELLER WERNER · MUELLER WERNER E G · MUELLER WERNER G
28 granted patents·29 pending applications·188 citations·filing 1994–2025
96Inventor score
Top patents by PatentIndex Score
57 records- 0190US12303598B2Pharmaceutical composition comprising a GLP-1-agonist and methionineSANOFI AVENTIS DEUTSCHLAND·Filed 2022·Granted May 20, 2025·1 cites·6 claims
- 0288US10028910B2Pharmaceutical composition comprising a GLP-1-agonist and methionineSANOFI AVENTIS DEUTSCHLAND·Filed 2017·Granted Jul 24, 2018·3 cites·4 claims
- 0387US6821980B1Substituted 5-benzyl-2,4-diaminopyrimidinesBASILEA PHARMACEUTICA AG·Filed 2000·Granted Nov 23, 2004·30 cites·28 claims
- 0486US9707176B2Pharmaceutical composition comprising a GLP-1 agonist and methionineBRUNNER-SCHWARZ ANETTE·Filed 2010·Granted Jul 18, 2017·8 cites·30 claims
- 0581US7119248B1Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereofMILTENYI BIOTEC GMBH·Filed 1994·Granted Oct 10, 2006·63 cites·8 claims
- 0680US7166589B2Quinoline derivativesHOFFMANN LA ROCHE·Filed 2006·Granted Jan 23, 2007·3 cites·19 claims
- 0780US7064134B2Quinoline derivativesHOFFMANN LA ROCHE·Filed 2005·Granted Jun 20, 2006·3 cites·20 claims
- 0879US7678818B2Anthranilamide and 2-amino-heteroarene-carboxamide compoundsHOFFMANN LA ROCHE·Filed 2007·Granted Mar 16, 2010·4 cites·20 claims
- 0979US6696467B2Quinoline derivativesHOFFMANN LA ROCHE·Filed 2003·Granted Feb 24, 2004·12 cites·22 claims
- 1079US2024390500A1Pharmaceutical composition comprising a glp-1 agonist, an insulin and methionineSANOFI AVENTIS DEUTSCHLAND·Filed 2024·Application pending·0 cites
- 1178US7294644B2CB 1 receptor inverse agonistsHOFFMANN LA ROCHE·Filed 2003·Granted Nov 13, 2007·10 cites·26 claims
- 1278US2024156071A1Enhanced immunoglobulin diversityTRIANNI INC·Filed 2023·Application pending·0 cites
- 1378US2025339372A1Pharmaceutical composition comprising a glp-1-agonist and methionineSANOFI AVENTIS DEUTSCHLAND·Filed 2025·Application pending·0 cites
- 1476US9345750B2Long-acting formulations of insulinSANOFI SA·Filed 2014·Granted May 24, 2016·2 cites·59 claims
- 1576US7259183B2Indole, indazole and indoline derivatives as CETP inhibitorsHOFFMANN LA ROCHE·Filed 2005·Granted Aug 21, 2007·4 cites·5 claims
- 1675US10029011B2Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionineHAGENDORF ANNIKA·Filed 2010·Granted Jul 24, 2018·7 cites·9 claims
- 1774US8901484B2Quantification of impurities for release testing of peptide productsSANOFI AVENTIS DEUTSCHLAND·Filed 2013·Granted Dec 2, 2014·2 cites·4 claims
- 1874US7572823B2Heteroaryl carboxamide compoundsHOFFMANN LA ROCHE·Filed 2007·Granted Aug 11, 2009·2 cites·16 claims
- 1974US6787558B2Quinoline derivativesHOFFMANN LA ROCHE·Filed 2002·Granted Sep 7, 2004·5 cites·26 claims
- 2074US2020215163A1Long-Acting Formulations of InsulinSANOFI SA·Filed 2019·Application pending·0 cites
- 2173US7579369B2CB 1 receptor inverse agonistsHOFFMANN LA ROCHE·Filed 2007·Granted Aug 25, 2009·1 cites·26 claims
- 2273US6818767B2Quinoline derivativesHOFFMANN LA ROCHE·Filed 2002·Granted Nov 16, 2004·5 cites·88 claims
- 2372US2021308225A1Long-Acting Formulations of InsulinSANOFI SA·Filed 2021·Application pending·0 cites
- 2471US7745477B2Heteroaryl and benzyl amide compoundsHOFFMANN LA ROCHE·Filed 2007·Granted Jun 29, 2010·1 cites·17 claims
- 2571US2023010106A1Single chain vh and heavy chain antibodiesTRIANNI INC·Filed 2022·Application pending·0 cites
- 2671US2019142747A1Pharmaceutical Composition Comprising a GLP-1-Agonist and MethionineSANOFI AVENTIS DEUTSCHLAND·Filed 2019·Application pending·0 cites
- 2770US7012073B2Quinoline derivativesHOFFMANN LA ROCHE·Filed 2004·Granted Mar 14, 2006·3 cites·20 claims
- 2869US2021038514A1Pharmaceutical composition comprising a glp-1-agonist and methionineSANOFI AVENTIS DEUTSCHLAND·Filed 2020·Application pending·0 cites
- 2969US2020384087A1Long-Acting Formulations of InsulinSANOFI SA·Filed 2020·Application pending·0 cites
- 3069US2020188516A1Pharmaceutical composition comprising a glp-1 agonist, an insulin and methionineSANOFI AVENTIS DEUTSCHLAND·Filed 2019·Application pending·0 cites
- 3168US2022133890A1Pharmaceutical composition comprising a glp-1 agonist, an insulin and methionineSANOFI AVENTIS DEUTSCHLAND·Filed 2021·Application pending·0 cites
- 3268US2024175049A1Long germline dh genes and long hcdr3 antibodiesTRIANNI INC·Filed 2024·Application pending·0 cites
- 3367US11889821B2Enhanced immunoglobulin diversityTRIANNI INC·Filed 2020·Granted Feb 6, 2024·0 cites·12 claims
- 3466US2019388511A1Long-Acting Formulations of InsulinSANOFI SA·Filed 2019·Application pending·0 cites
- 3565US2019046616A1Long-Acting Formulations of InsulinSANOFI SA·Filed 2018·Application pending·0 cites
- 3659US2024423175A1Transgenic mammals and methods of use thereofTRIANNI INC·Filed 2022·Application pending·0 cites
- 3759US2014379277A1Quantification of impurities for release testing of peptide productsVOGEL MARTIN·Filed 2014·Application pending·0 cites
- 3858US11414478B2Single chain VH and heavy chain antibodiesTRIANNI INC·Filed 2018·Granted Aug 16, 2022·0 cites·6 claims
- 3958US2016339084A1Long-Acting Formulations of InsulinSANOFI SA·Filed 2016·Application pending·0 cites
- 4058US2016228516A1Long-Acting Formulations of InsulinSANOFI SA·Filed 2016·Application pending·0 cites
- 4157US2015164999A1Long-Acting Formulations of InsulinSANOFI SA·Filed 2015·Application pending·0 cites
- 4257US2007299245A1P277 peptide formulations or variants thereof having optimized stabilitySANOFI AVENTIS DEUTSCHLAND·Filed 2007·Application pending·0 cites
- 4356US6257079B1Tablet testing applianceERWEKA GMBH·Filed 1998·Granted Jul 10, 2001·19 cites·19 claims
- 4456US2024215556A1Transgenic rodents expressing chimeric equine-rodent antibodies and methods of use thereofTRIANNI INC·Filed 2022·Application pending·0 cites
- 4554US11946063B2Long germline DH genes and long HCDR3 antibodiesTRIANNI INC·Filed 2018·Granted Apr 2, 2024·0 cites·7 claims
- 4654US2013172335A12,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compoundsHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 4754US2018200370A1Pharmaceutical Composition Comprising a GLP-1 Agonist, an Insulin and MethionineSANOFI AVENTIS DEUTSCHLAND·Filed 2017·Application pending·0 cites
- 4853US2007101446A1Antibodies against epitopes with homology to self antigens, methods of preparationMILTENYI BIOTEC GMBH·Filed 2006·Application pending·0 cites
- 4953US2005049413A1Quinoline derivativesFiled 2004·Application pending·0 cites
- 5052US8450313B22,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compoundsHUNZIKER DANIEL·Filed 2012·Granted May 28, 2013·0 cites·19 claims
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Werner Mueller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →